← Back to Search

Behavioural Intervention

Questionnaire Formats for ADHD

N/A

Recruiting

Led By Roni Kraut

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

19 - 65 years old

Be older than 18 years old

Must not have

Patients who do not have the capacity to complete the form (e.g., cognitive impairment, unable to read English, unable to use a computer)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, estimated to be 2 months

Awards & highlights

No Placebo-Only Group

Summary

This trial focuses on the use of a questionnaire called the Adult ADHD Self-Report Scale in family medicine clinics to identify ADHD in adults. However, the questionnaire format may make it easy for patients to figure

Who is the study for?

This trial is for individuals who are being screened for Attention Deficit Hyperactivity Disorder (ADHD) in family medicine clinics. The eligibility criteria details are not provided, so it's unclear who exactly can or cannot participate.

What is being tested?

The study is testing different formats of the Adult ADHD Self-Report Scale (ASRS). It compares three versions: one without shading and with grouping, another with shading but no grouping, and a third without either feature.

What are the potential side effects?

Since this trial involves only changes to the format of a questionnaire and does not include medication or medical procedures, there are no direct physical side effects associated with participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 19 and 65 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am able to complete forms and do not have cognitive impairments.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, estimated to be 2 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, estimated to be 2 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, estimated to be 2 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Screen positive rate

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: ASRS without shading and without groupingExperimental Treatment1 Intervention

These participants will receive the ASRS form that does not have shading for the screen positive response options and has the questions ungrouped (ie, the headings "Part A" and "Part B" are removed).

Group II: ASRS without shading and with groupingExperimental Treatment1 Intervention

These participants will receive the ASRS form that does not have shading for the screen positive response options and has the questions grouped (ie, the headings "Part A" and "Part B" will remain on the form).

Group III: ASRS with shading and without groupingExperimental Treatment1 Intervention

These participants will receive the ASRS form that has the screen positive response options shaded and has the questions ungrouped (ie, the headings "Part A" and "Part B" are removed).

Group IV: Standard ASRS: with shading and with groupingActive Control1 Intervention

These participants will receive the standard ASRS form. This form has the positive response options for each question shaded and has the questions grouped (ie, the headings "Part A" and "Part B" will remain on the form).

0 / 2Eligibility criteria met